Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Enerpac Tool Group Schedules First Quarter Fiscal 2025 Earnings Release and Conference Call
-
Theratechnologies Announces Resumed Production of EGRIFTA SV®
-
Outlook Therapeutics® Announces Executive Leadership Transition
-
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Colliers announces appointment of John Sullivan to Board of Directors
-
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Lake Shore Savings Bank Announces Termination of OCC Consent Order
-
Ryan Smith Named as Chief Digital and Information Officer at Intermountain Health
-
DTE Energy Board of Directors declares quarterly dividend
-
Redwood Living, Inc. announces 2024 Redwood Cares recipients
-
APA Corporation Commences Private Exchange and Tender Offers for Certain Series of Outstanding Apache Corporation Notes and Debentures and Solicitation of Consents to Amend Certain Related Indentures
-
Uniti Group Inc. to Participate at the Raymond James 2024 TMT & Consumer Conference
-
Uniti Group Inc. to Participate at the Raymond James 2024 TMT & Consumer Conference
-
Americold's Fully Automated Russellville Facility Recognized as the Winner of the 2024 Built By The Best Award by the Controlled Environment Building Association
-
Join Alliance Entertainment’s Exclusive Live Investor Webinar and Q&A Session on December 10
-
Onity Group Announces Closing of MSR Asset Vehicle Sale to Oaktree
-
FTAI Aviation Announces Sale of Offshore Energy Vessels, Continuing Focus on Providing Power for the Aftermarket
-
Enact Mortgage Insurance Enters into Two Quota Share Reinsurance Agreements
-
Join Alliance Entertainment’s Exclusive Live Investor Webinar and Q&A Session on December 10
-
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Amarna Therapeutics Partners with NorthX Biologics to Advance Nimvec™ AM510 Gene Therapy Development
-
TeraWulf Announces November 2024 Production and Operations Update
-
Intuitive Machines Announces Launch of Public Offering of its Class A Common Stock and Concurrent Private Placement
-
SPS Commerce to Present at the Nasdaq 51st Investor Conference
-
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
-
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
-
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update
-
Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-
-
Bionomics to Present at the 2024 American College of Neuropsychopharmacology Annual Meeting
-
NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome
-
Pool Corporation to Participate in the Nasdaq 51st Investor Conference
-
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
TTM Technologies, Inc. To Exhibit at the 2024 International Electronics Circuit Exhibition in Shenzhen, China
-
MachTen, Inc. Reports Third Quarter 2024 Financial Results
-
Latham Group, Inc. to Participate in the Wolfe December Conference
-
XPO Provides North American LTL Operating Data for November 2024
-
LPL Financial to present at the Goldman Sachs Financial Services Conference
-
Anfield Energy Inc. Announces Shareholder Approval of Plan of Arrangement
-
IREN announces proposed convertible notes offering
-
Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
-
Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF Class
-
Premium Global Income Split Corp. Declares Monthly Distribution
-
Premium Income Corporation Announces Monthly Distribution
-
FormFactor Announces Participation in 13th Annual NYC Summit
-
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024
-
Parsons and Globalstar Announce Partnership, Demonstrate First Software Defined Satellite Communication Solutions in Low Earth Orbit
-
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
-
PrairieSky Royalty Declares Quarterly Dividend
